-
Document de presse | 2022.06.15
COVID-19: Identification of broadly SARS-CoV-2 neutralizing monoclonal antibodies
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised people are at greater risk of developing severe forms of COVID-19. Monoclonal antibodies currently offer the best approach, both as a preventive and curative treatment for these patients. Scientists from the Institut Pasteur and...
-
Portrait | 2023.04.14
Sarah Bonnet, tickologist and educator
Sarah Bonnet is a "tickologist" – she specializes in the study of ticks. More broadly, she is a veterinarian entomologist and medical, a professor and scientist with a passion for field work. Her research is focused on the little-known field of ticks and their many species. She is an enthusiastic educator who loves sharing her expertise and plans for future research. The upheavals we are...
-
Document de presse | 2023.10.25
New discovery concerning receptors used by coronaviruses to enter human cells
The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in 2019. This raises the question of why one coronavirus affects humans more severely than another. Scientists at the Institut Pasteur, Université Paris Cité and the VRI have now provided part of the...
-
News | 2022.07.08
Conversation: 2021, a pivotal year for the Institut Pasteur's future
Institut Pasteur Board of Governors Chairman Christian Vigouroux and President Prof. Sir Stewart Cole share their thoughts on the year's highlights. 2021 was a pivotal year poised between maintaining financial stability and supporting scientific projects.
-
Document de presse | 2025.03.17
Hepatitis B: new rapid diagnostic test to halt mother-to-child transmission
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting hepatitis B to their babies. This diagnostic tool could help eliminate hepatitis B by preventing mother-to-child transmission during childbirth, especially in low- and middle-income countries. Hepatitis B is...
-
Article | 2017.09.12
Pasteur-Paris University enrollment 2018
The 2017-2018 call for enrollment of students in October 2018 is open.
-
Document de presse | 2015.11.04
4th Edition of the Sanofi - Institut Pasteur Awards
Sanofi and the Institut Pasteur have attributed today the Sanofi - Institut Pasteur Awards for the fourth year in a row. Four major researchers with international recognition have been rewarded for their works in two major fields for global health: tropical and neglected diseases and immunology. Doctor Marco Vignuzzi - laureate in the Junior category - Viral Populations and Pathogenesis...
-
Document de presse | 2014.06.01
Elucidating the pathogenic mechanism of meningococcal meningitis
Neisseria meningitidis, also called meningococcus, is a bacterium responsible for meningitis and septicemia[1]. Its most serious form, purpura fulminans, is often fatal. This bacterium, which is naturally present in humans in the nasopharynx, is pathogenic if it reaches the blood stream. Teams led by Dr. Sandrine Bourdoulous, CNRS senior researcher at the Institut Cochin (CNRS/INSERM/Université...
-
Document de presse | 2014.08.03
The emergence of neonatal group B streptococcal infections explained
Scientists from the Institut Pasteur and the CNRS, in collaboration with teams from the CNRS/Inserm/Paris Descartes University–Sorbonne Paris Cité (based at the Institut Cochin) and the Wellcome Trust (Sanger Institute), have recently revealed the cause behind the emergence in the 1960s of neonatal infections due to group B streptococcus. These findings, published in Nature Communications...
-
Document de presse | 2013.01.06
Retracing the evolutionary history and emergence of tuberculosis
In association with CEA-Genoscope and the Sanger Institute, scientists at the Institut Pasteur in Paris, the CNRS, INSERM, the Institut Pasteur of Lille, and Université Lille 2 have recently determined the origin of the emergence of the Mycobacterium tuberculosis bacterium, the main causative agent of tuberculosis. Researchers have also provided insights into its evolutionary success. They have...